U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H14O6
Molecular Weight 326.3002
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of CINFENOAC

SMILES

OC(=O)COC1=CC=C(C=C1)C(=O)\C=C\C2=CC=C(C=C2)C(O)=O

InChI

InChIKey=HXSSCTOWBWPFEV-XCVCLJGOSA-N
InChI=1S/C18H14O6/c19-16(10-3-12-1-4-14(5-2-12)18(22)23)13-6-8-15(9-7-13)24-11-17(20)21/h1-10H,11H2,(H,20,21)(H,22,23)/b10-3+

HIDE SMILES / InChI

Description

Cinfenoac is a chalcone derivative patented by a pharmaceutical company Biorex Laboratories from the UK. The compound is claimed for the treatment of inflammatory and allergic conditions, as well as for the treatment of the ulcerous condition of the gastrointestinal tract.

Approval Year

Unknown
139594
Name Type Language
CINFENOAC
INN  
INN  
Official Name English
P-(2-(.ALPHA.-CARBOXY-P-ANISOYL)VINYL)BENZOIC ACID
Common Name English
cinfenoac [INN]
Common Name English
Code System Code Type Description
NCI_THESAURUS
C171849
Created by admin on Fri Dec 15 16:24:06 GMT 2023 , Edited by admin on Fri Dec 15 16:24:06 GMT 2023
PRIMARY
FDA UNII
055F0R97NJ
Created by admin on Fri Dec 15 16:24:06 GMT 2023 , Edited by admin on Fri Dec 15 16:24:06 GMT 2023
PRIMARY
SMS_ID
100000081064
Created by admin on Fri Dec 15 16:24:06 GMT 2023 , Edited by admin on Fri Dec 15 16:24:06 GMT 2023
PRIMARY
ChEMBL
CHEMBL2104569
Created by admin on Fri Dec 15 16:24:06 GMT 2023 , Edited by admin on Fri Dec 15 16:24:06 GMT 2023
PRIMARY
EVMPD
SUB06295MIG
Created by admin on Fri Dec 15 16:24:06 GMT 2023 , Edited by admin on Fri Dec 15 16:24:06 GMT 2023
PRIMARY
CAS
66984-59-6
Created by admin on Fri Dec 15 16:24:06 GMT 2023 , Edited by admin on Fri Dec 15 16:24:06 GMT 2023
PRIMARY
PUBCHEM
6443801
Created by admin on Fri Dec 15 16:24:06 GMT 2023 , Edited by admin on Fri Dec 15 16:24:06 GMT 2023
PRIMARY
INN
4599
Created by admin on Fri Dec 15 16:24:06 GMT 2023 , Edited by admin on Fri Dec 15 16:24:06 GMT 2023
PRIMARY
EPA CompTox
DTXSID00867256
Created by admin on Fri Dec 15 16:24:06 GMT 2023 , Edited by admin on Fri Dec 15 16:24:06 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of CINFENOAC
SALT/SOLVATE (PARENT)
Structure of CINFENOAC DISODIUM
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966